KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelon (EXC) Common Equity (2016 - 2025)

Historic Common Equity for Exelon (EXC) over the last 17 years, with Q4 2025 value amounting to $28.8 billion.

  • Exelon's Common Equity rose 697.23% to $28.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $28.8 billion, marking a year-over-year increase of 697.23%. This contributed to the annual value of $28.8 billion for FY2025, which is 697.23% up from last year.
  • Exelon's Common Equity amounted to $28.8 billion in Q4 2025, which was up 697.23% from $28.1 billion recorded in Q3 2025.
  • In the past 5 years, Exelon's Common Equity registered a high of $34.5 billion during Q2 2021, and its lowest value of $12.4 billion during Q4 2021.
  • In the last 5 years, Exelon's Common Equity had a median value of $19.1 billion in 2022 and averaged $21.4 billion.
  • In the last 5 years, Exelon's Common Equity plummeted by 6167.43% in 2022 and then skyrocketed by 9170.2% in 2025.
  • Exelon's Common Equity (Quarter) stood at $12.4 billion in 2021, then increased by 8.17% to $13.4 billion in 2022, then increased by 7.48% to $14.4 billion in 2023, then surged by 87.43% to $26.9 billion in 2024, then grew by 6.97% to $28.8 billion in 2025.
  • Its Common Equity stands at $28.8 billion for Q4 2025, versus $28.1 billion for Q3 2025 and $27.6 billion for Q2 2025.